Packages : Disclosure of Price Sensitive Information - Commencement of Acceptance Period for the Shareholders of Sanofi Aventis Pakistan Limited
August 15, 2022 at 01:53 am EDT
Share
Sec/96/PKGS
Karachi
15 August 2022
The General Manager
Pakistan Stock Exchange Limited
Stock Exchange Building,
Stock Exchange Road,
Karachi
Commissioner
Company Law Division
Securities & Exchange Commission of Pakistan
NIC Building, Jinnah Avenue,Blue Area,
Islamabad
Executive Director / HOD
Offsite-II Department
Supervision Division
Securities & Exchange Commission of Pakistan
63, NIC Building, Jinnah Avenue
Blue Area
Islamabad
Dear Sirs,
SUB: PUBLIC ANNOUNCEMENT INFORMING THE SHAREHOLDERS OF SANOFI AVENTIS PAKISTAN LIMITED REGARDING COMMENCEMENT OF THE ACCEPTANCE PERIOD
In accordance with Sections 96 and 131 of the Securities Act, 2015 and Regulation 5.6.1(a) of the Pakistan Stock Exchange Rule Book, we are enclosing herewith a Form disclosing publishing of newspaper notification on August 15, 2022 by Arif Habib Limited, Manager to the Offer, regarding commencement of the Acceptance Period in terms of Packages Limited (the "Company") offer to purchase ordinary shares of Sanofi Aventis Pakistan Limited under public announcement of offer made by the Company in newspapers on June 30, 2022.
Please inform the members of the Exchange accordingly.
Yours sincerely,
For PACKAGES LIMITED
Iqra Sajjad
Company Secretary
Encl: As above
DISCLOSURE FORM
INTERMS OF SECTIONS 96 AND 131 OF THE SECURITIES ACT, 2015
Name of Company
Packages Limited
Date of Report
15 August 2022
Name of Company as specified in
Packages Limited
The Memorandum
Company's Registered Office
4th Floor, The Forum
Suite # 416-422,G-20, Block 9
Khayaban-e-Jami, Clifton
Karachi-75600
Contact Information
Tel: (021) 35860252
Disclosure of inside information by listed company:
This is with reference to the public offer published by Arif Habib Limited (Manager to the Offer) on June 30, 2022 on behalf of the Company to acquire upto 585,254 ordinary shares (minimum level of acceptance of 409,677 shares) of Sanofi Aventis Pakistan Limited ("Target Company") comprising 6.07% of the issued ordinary share capital thereof at an offer price of PKR 1,704/- per ordinary share pursuant to the Securities Act, 2015 (the Act) and the Listed Companies (Substantial Acquisition of Voting Shares and Takeovers) Regulations, 2017 (the Regulations).
Today, the Manager to the Offer has published a notification in newspapers namely Business Recorder [English] and Nawa-e-Waqt [Urdu] (copies attached) on behalf of the Company stating that the acceptance period for the acquisition of shares of the Target Company under the Offer will commence from August 17, 2022 and will end on August 23, 2022 (both days inclusive).
Pursuant to the requirements of the Securities Act, 2015, the Company has duly caused this form/statement to be signed on its behalf by the undersigned hereunto duly authorized.
For and on behalf of
PACKAGES LIMITED
Iqra Sajjad
Company Secretary
Attachments
Original Link
Original Document
Permalink
Disclaimer
Packages Ltd. published this content on 15 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 August 2022 05:52:04 UTC.
Packages Limited is a Pakistan-based investment holding company. The Company's segments include Packaging, Consumer Products, Ink, Real Estate, Paper and Board, Plastic, Pharmaceutical Products, Corn Starch Products, and Unallocated. Packaging segment manufactures and markets packing products. Consumer Products segment manufactures and markets consumer/tissue products. Ink segment manufactures and markets industrial and commercial ink products. Real Estate segment constructs and develops real estate. Paper and Board segment manufactures and markets paper and board products. Plastic segment manufactures and markets biaxially oriented polypropylene film and cast polypropylene films. Pharmaceutical Products segment manufactures, sales and trades pharmaceutical and related products. Corn Starch Products segment manufactures and sells corn-based starch products, its derivatives, by-products and trading of corn. Unallocated segment includes workshop and other general business.